Aviragen and Vaxart Amend Terms of Merger Agreement

Aviragen Therapeutics (NASDAQ:AVIR) and Vaxart announced that the companies have agreed to amend the terms of their previously announced merger...

Aviragen Will Review Strategic Alternatives And Gives Update

Aviragen Therapeutics (NASDAQ:AVIR) announced a review of strategic alternatives and provided a corporate update on the future of the company.